Results 171 to 180 of about 54,313 (259)
Sustained Idiopathic Outflow Tract Ventricular Tachycardia: Clinical Evidence for RVOT Predominance
ABSTRACT Background Idiopathic outflow tract premature ventricular contractions (PVCs) are most commonly localized in the right ventricular outflow tract (RVOT). The clinical significance of sustained outflow tract ventricular tachycardia (OT‐VT) regarding any predominance to one specific anatomic area remains uncertain.
Moneeb Khalaph +16 more
wiley +1 more source
ABSTRACT Background The left atrial posterior wall (LAPW) is often targeted in atrial fibrillation (AF) ablation due to its shared properties with pulmonary veins. However, substrate‐guided approaches using structural markers have shown inconsistent results.
Michael M. Malaty +7 more
wiley +1 more source
Role of Computed Tomography in Cardiac Electrophysiology. [PDF]
Sultana S +5 more
europepmc +1 more source
ABSTRACT Introduction Intravenous lidocaine is frequently used for refractory ventricular arrhythmia (VA). Atrial fibrillation (AF) is a common comorbidity in VA patients. Lidocaine poses theoretical risks of hemodynamic compromise and pro‐arrhythmia, including AF with rapid ventricular rates (RVR).
Andrea N. Keithler +10 more
wiley +1 more source
Preclinical Experience Using 4D Intracardiac Echocardiography to Guide Cardiac Electrophysiology Procedures. [PDF]
Blumenthal CJ +9 more
europepmc +1 more source
Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial
ABSTRACT Introduction Obesity represents a prevalent condition with multiple comorbidities, including atrial fibrillation (AF). Dronedarone, an antiarrhythmic drug (AAD), has demonstrated efficacy in patients with paroxysmal/persistent AF and cardiovascular (CV) risk factors.
Mate Vamos +3 more
wiley +1 more source
From bits to bedside: entering the age of digital twins in cardiac electrophysiology. [PDF]
Bhagirath P +4 more
europepmc +1 more source
ABSTRACT Background Cardiac amyloidosis is commonly associated with cardiac conduction disease. We sought to determine the prevalence of advanced conduction disease requiring a pacemaker in patients with known cardiac amyloidosis to evaluate current screening practices among patients receiving pacemakers.
Peishan Cai +4 more
wiley +1 more source

